Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. [electronic resource]
Producer: 20070608Description: 1960-6 p. digitalISSN:- 1527-7755
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Deoxycytidine -- administration & dosage
- Double-Blind Method
- Erlotinib Hydrochloride
- Female
- Humans
- International Agencies
- Male
- Middle Aged
- Pancreatic Neoplasms -- drug therapy
- Placebos
- Prognosis
- Quinazolines -- administration & dosage
- Survival Rate
- Treatment Outcome
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.